...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: 50/50 at best on Zen being sold this year IMO..

Lol - go tug on penny with a wooden shoe buddy & roll out some copper - fellas like u don't do favours for anybody Dutch 

Share
New Message
Please login to post a reply